We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$334M
AUM Growth
+$47.3M
Cap. Flow
+$13.4M
Cap. Flow %
4.02%
Top 10 Hldgs %
23.72%
Holding
289
New
27
Increased
129
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.41M
2
CVS icon
CVS Health
CVS
+$1.67M
3
WFC icon
Wells Fargo
WFC
+$1.58M
4
TGT icon
Target
TGT
+$1.34M
5
ABBV icon
AbbVie
ABBV
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.34%
2 Technology 13%
3 Industrials 10.2%
4 Financials 9.85%
5 Energy 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARTNA icon
126
Artesian Resources
ARTNA
$355M
$701K 0.21%
18,812
+3
+0% +$111
DE icon
127
Deere & Co
DE
$160B
$701K 0.21%
4,383
BN icon
128
Brookfield
BN
$104B
$700K 0.21%
42,044
+3
+0% +$47
V icon
129
Visa
V
$684B
$699K 0.21%
4,474
+600
+15% +$86.5K
VOO icon
130
Vanguard S&P 500 ETF
VOO
$979B
$682K 0.2%
2,629
+600
+30% +$150K
YORW icon
131
York Water
YORW
$502M
$668K 0.2%
19,477
+3
+0% +$100
MLM icon
132
Martin Marietta Materials
MLM
$31.5B
$654K 0.2%
3,250
-300
-8% -$56K
LLY icon
133
Eli Lilly
LLY
$1.02T
$652K 0.2%
5,021
-2,400
-32% -$292K
IWM icon
134
iShares Russell 2000 ETF
IWM
$79.8B
$630K 0.19%
4,113
-336
-8% -$50.5K
EXPD icon
135
Expeditors International
EXPD
$22B
$628K 0.19%
8,279
CMCSA icon
136
Comcast
CMCSA
$85B
$626K 0.19%
15,655
+1,105
+8% +$41.6K
DOV icon
137
Dover
DOV
$27.6B
$622K 0.19%
6,625
+626
+10% +$54.1K
CPK icon
138
Chesapeake Utilities
CPK
$3.19B
$613K 0.18%
6,721
-250
-4% -$22.2K
ECL icon
139
Ecolab
ECL
$78.1B
$613K 0.18%
3,474
-1,100
-24% -$179K
MO icon
140
Altria Group
MO
$114B
$610K 0.18%
10,625
-2,249
-17% -$115K
USB icon
141
US Bancorp
USB
$98.2B
$609K 0.18%
12,624
+478
+4% +$24K
MNR
142
DELISTED
Monmouth Real Estate Investment Corp
MNR
$607K 0.18%
46,077
+347
+0.8% +$4.61K
NVS icon
143
Novartis
NVS
$297B
$606K 0.18%
7,040
+17
+0.2% +$1.36K
IVW icon
144
iShares S&P 500 Growth ETF
IVW
$73.8B
$599K 0.18%
13,896
+3,968
+40% +$163K
TBT icon
145
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
$597K 0.18%
18,516
-200
-1% -$7K
IVE icon
146
iShares S&P 500 Value ETF
IVE
$49B
$588K 0.18%
5,219
+1,826
+54% +$201K
CCMP
147
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$587K 0.18%
5,240
ADM icon
148
Archer Daniels Midland
ADM
$38.2B
$570K 0.17%
13,200
-400
-3% -$17.1K
CBSH icon
149
Commerce Bancshares
CBSH
$8.53B
$564K 0.17%
13,663
TIP icon
150
iShares TIPS Bond ETF
TIP
$14.5B
$562K 0.17%
4,972
+39
+0.8% +$4.33K

Similar funds

Boenning & Scattergood's Q1 2019 Portfolio in Review

As of Q1 2019, Boenning & Scattergood held 289 positions worth $334M, up 17% from $287M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boenning & Scattergood deployed $13.4M of net new capital in Q1 2019, opening 27 new positions and adding to 129 existing holdings. Its largest new stake was Target: 18,390 shares worth $1.48M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Universal Health Realty Income Trust, an estimated $5.13M trimmed.

  • Boenning & Scattergood's largest Q1 2019 buy was Target: 18,390 shares worth $1.48M.
  • Boenning & Scattergood added most to Vanguard FTSE Developed Markets ETF in Q1 2019, an estimated $2.41M increase.
  • Boenning & Scattergood's biggest Q1 2019 reduction was Universal Health Realty Income Trust, cutting an estimated $5.13M.
  • Boenning & Scattergood fully exited iShares Biotechnology ETF in Q1 2019, selling an estimated $1.13M.
  • Boenning & Scattergood's ten largest holdings make up 24% of its $334M portfolio in Q1 2019.
  • Boenning & Scattergood opened 27 new positions and closed 9 in Q1 2019.
  • Boenning & Scattergood's portfolio value rose 17% quarter-over-quarter to $334M.

Based on Boenning & Scattergood's 13F filing for Q1 2019, filed 22 Apr 2019.